KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹82 Cr | ₹58 Cr | ₹45 Cr | ₹7.05 Cr | ₹34 Cr |
What is the latest Net Current Assets ratio of KILITCH DRUGS (INDIA) ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹82 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹45 Cr |
Mar2021 | ₹7.05 Cr |
Mar2020 | ₹34 Cr |
How is Net Current Assets of KILITCH DRUGS (INDIA) Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹82 Cr | 42.15 | |
Mar2023 | ₹58 Cr | 28.34 | |
Mar2022 | ₹45 Cr | 536.00 | |
Mar2021 | ₹7.05 Cr | -79.16 | |
Mar2020 | ₹34 Cr | - |
Compare Net Current Assets of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹649.1 Cr | 4.1% | 1.7% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 4.1% |
1.7% |
14.5% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses